Hypotensive effects of clonidine and chlorthalidone. Controlled clinical trial of drugs administered singly and in combination.
D000469:Alkaline Phosphatase / Q000097:blood; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002752:Chlorthalidone / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003298:Coombs Test; D003404:Creatinine / Q000097:blood; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D010919:Placebos; D011188:Potassium / Q000097:blood; D012160:Retina / Q000187:drug effects; D012964:Sodium / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014556:Urine / Q000032:analysis
D000959:Antihypertensive Agents; D001786:Blood Glucose; D007093:Imidazoles; D010919:Placebos; D014527:Uric Acid; D012964:Sodium; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D002752:Chlorthalidone; D001663:Bilirubin; D011188:Potassium